Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Gregory Schwartz

Concepts (589)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
74
2025
293
15.970
 Why?
Anticholesteremic Agents
55
2026
152
12.630
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
57
2025
439
7.760
 Why?
Lipoprotein(a)
22
2025
68
7.460
 Why?
Antibodies, Monoclonal, Humanized
47
2025
985
6.430
 Why?
Cholesterol, LDL
53
2026
358
6.370
 Why?
Myocardial Infarction
45
2026
1209
4.790
 Why?
Cardiovascular Diseases
41
2026
2168
4.380
 Why?
Proprotein Convertase 9
29
2025
87
3.730
 Why?
Coronary Disease
16
2020
383
3.040
 Why?
Angina, Unstable
19
2019
82
2.750
 Why?
Heptanoic Acids
23
2016
67
2.590
 Why?
Cholesterol, HDL
13
2020
200
2.590
 Why?
Diabetes Mellitus, Type 2
23
2025
2583
2.510
 Why?
Dyslipidemias
9
2025
181
2.460
 Why?
Sulfhydryl Compounds
10
2020
189
2.440
 Why?
Hypercholesterolemia
11
2023
92
2.410
 Why?
Pyrroles
23
2016
217
2.390
 Why?
Stroke
32
2026
1256
2.260
 Why?
Quinazolinones
7
2021
19
2.110
 Why?
Serine Proteinase Inhibitors
6
2025
51
2.100
 Why?
Atherosclerosis
12
2026
409
1.590
 Why?
Myocardial Ischemia
17
2018
285
1.570
 Why?
Thiazolidinediones
10
2017
138
1.540
 Why?
Secondary Prevention
11
2019
254
1.530
 Why?
Double-Blind Method
43
2025
2029
1.520
 Why?
Cholesterol
12
2022
406
1.510
 Why?
Treatment Outcome
68
2026
11679
1.430
 Why?
Oxazoles
9
2022
48
1.360
 Why?
Esters
9
2020
78
1.350
 Why?
Amides
9
2020
101
1.330
 Why?
Thiophenes
9
2022
128
1.290
 Why?
Cholesterol Ester Transfer Proteins
5
2016
22
1.280
 Why?
Hypoglycemic Agents
18
2024
1387
1.230
 Why?
Risk Factors
45
2024
10779
1.220
 Why?
Aged
83
2026
25913
1.210
 Why?
Myocardial Contraction
14
2013
298
1.140
 Why?
Middle Aged
87
2026
35875
1.130
 Why?
Ventricular Fibrillation
3
2017
64
1.130
 Why?
Humans
176
2026
144759
1.130
 Why?
Swine
35
2023
833
1.100
 Why?
Risk Assessment
21
2025
3671
1.090
 Why?
Coronary Artery Disease
6
2023
741
1.080
 Why?
C-Reactive Protein
11
2022
416
1.080
 Why?
Insulin Resistance
10
2018
1241
1.060
 Why?
Myocardium
23
2004
939
1.010
 Why?
Antibodies, Monoclonal
7
2023
1519
1.010
 Why?
Metabolic Syndrome
4
2013
354
1.000
 Why?
Diabetic Angiopathies
2
2019
263
1.000
 Why?
Male
110
2026
72315
0.980
 Why?
Female
116
2026
78271
0.920
 Why?
Myocardial Reperfusion Injury
5
2013
137
0.910
 Why?
Ischemic Attack, Transient
6
2018
71
0.900
 Why?
Heart
10
2009
636
0.870
 Why?
PPAR gamma
6
2022
176
0.860
 Why?
Lipoproteins, HDL
4
2019
101
0.850
 Why?
Proteins
3
2020
1021
0.850
 Why?
RNA, Small Interfering
11
2026
635
0.840
 Why?
Hyperlipoproteinemia Type II
4
2026
32
0.830
 Why?
Proprotein Convertases
2
2014
16
0.810
 Why?
Peripheral Arterial Disease
3
2020
503
0.810
 Why?
Triglycerides
5
2024
520
0.770
 Why?
Biomarkers
24
2025
4271
0.770
 Why?
Renal Insufficiency, Chronic
6
2026
653
0.700
 Why?
Fatty Acids, Nonesterified
4
2018
158
0.700
 Why?
Randomized Controlled Trials as Topic
19
2024
1720
0.700
 Why?
Time Factors
22
2025
7173
0.680
 Why?
Patient Admission
2
2021
218
0.670
 Why?
Insulin
7
2021
2507
0.660
 Why?
Coronary Circulation
18
2004
136
0.660
 Why?
Cardiovascular Agents
4
2021
164
0.640
 Why?
Molecular Targeted Therapy
2
2014
432
0.640
 Why?
Hospitalization
5
2019
2433
0.620
 Why?
Recurrence
11
2021
1135
0.600
 Why?
Energy Metabolism
13
2004
935
0.570
 Why?
Swine, Miniature
3
2013
89
0.550
 Why?
Adiponectin
2
2018
244
0.550
 Why?
Lipid Metabolism
2
2014
527
0.540
 Why?
Venous Thrombosis
1
2020
194
0.530
 Why?
Brain Ischemia
5
2022
358
0.530
 Why?
Ezetimibe
4
2023
24
0.530
 Why?
Heart Arrest
4
2017
407
0.520
 Why?
Aldosterone
1
2017
43
0.500
 Why?
Rosuvastatin Calcium
4
2022
21
0.500
 Why?
Cardiovascular System
1
2018
137
0.490
 Why?
Venous Thromboembolism
1
2020
324
0.460
 Why?
Phospholipids
4
2025
213
0.450
 Why?
Arteriosclerosis
2
2014
84
0.440
 Why?
Patient Readmission
2
2021
758
0.430
 Why?
Drug Therapy, Combination
6
2020
1047
0.420
 Why?
Adenosine Triphosphate
14
2017
498
0.420
 Why?
Magnetic Resonance Spectroscopy
17
2019
630
0.400
 Why?
Metformin
1
2017
318
0.400
 Why?
Diabetes Complications
3
2021
222
0.390
 Why?
Apolipoproteins
4
2025
38
0.390
 Why?
Animals
49
2023
38058
0.380
 Why?
Heart Failure
10
2026
2323
0.380
 Why?
Phosphocreatine
13
1995
44
0.380
 Why?
Phosphates
7
2024
180
0.370
 Why?
Ventricular Function, Left
9
2004
541
0.360
 Why?
Veterans
3
2023
1603
0.360
 Why?
Blood Pressure
11
2012
1769
0.360
 Why?
Hemodynamics
11
2007
1121
0.360
 Why?
Proportional Hazards Models
9
2019
1325
0.360
 Why?
Coronary Vessels
8
2012
251
0.350
 Why?
Obesity
3
2024
3077
0.350
 Why?
Uncertainty
1
2012
144
0.350
 Why?
Dietary Fats
2
2013
314
0.340
 Why?
Atrial Fibrillation
2
2022
550
0.330
 Why?
Drug Administration Schedule
8
2019
779
0.330
 Why?
Follow-Up Studies
11
2023
5408
0.320
 Why?
Glucose
5
2020
1047
0.320
 Why?
Systole
7
2001
178
0.320
 Why?
Fluorobenzenes
2
2014
17
0.320
 Why?
Reperfusion Injury
2
2005
300
0.310
 Why?
Research Design
3
2009
1135
0.310
 Why?
Risk
9
2018
911
0.310
 Why?
Phospholipases A2, Secretory
4
2014
14
0.310
 Why?
Diastole
5
2001
143
0.290
 Why?
Ischemia
1
2012
421
0.290
 Why?
Ventricular Dysfunction, Right
3
2007
248
0.280
 Why?
KATP Channels
1
2008
17
0.270
 Why?
Surgical Procedures, Operative
4
2017
270
0.270
 Why?
Apolipoproteins B
5
2022
47
0.270
 Why?
Cohort Studies
6
2023
5960
0.270
 Why?
Clinical Trials, Phase III as Topic
3
2024
117
0.260
 Why?
Chromans
3
2004
23
0.260
 Why?
Acute Disease
9
2012
1030
0.260
 Why?
Hypolipidemic Agents
3
2022
88
0.260
 Why?
Peptide Fragments
4
2024
699
0.260
 Why?
Dose-Response Relationship, Drug
7
2019
2027
0.260
 Why?
Mortality
3
2017
375
0.260
 Why?
Survival Analysis
7
2018
1382
0.260
 Why?
Incidence
7
2022
2879
0.250
 Why?
Veterans Health
2
2020
189
0.250
 Why?
Apolipoprotein B-100
2
2025
13
0.250
 Why?
Potassium
2
2014
152
0.250
 Why?
Sodium
2
2020
197
0.250
 Why?
Cholecalciferol
1
2007
60
0.250
 Why?
Diet
3
2025
1273
0.240
 Why?
Pyrimidines
2
2014
532
0.240
 Why?
Prognosis
6
2024
4282
0.240
 Why?
Sulfonamides
2
2014
580
0.240
 Why?
Subtilisins
2
2023
9
0.240
 Why?
Hyperlipoproteinemia Type III
1
2025
4
0.230
 Why?
Fenofibrate
1
2005
28
0.230
 Why?
Endpoint Determination
1
2026
83
0.230
 Why?
Phenylurea Compounds
1
2026
112
0.230
 Why?
Dobutamine
5
2000
24
0.220
 Why?
Acetates
3
2019
80
0.220
 Why?
Adrenergic beta-Antagonists
3
2013
250
0.220
 Why?
Myelodysplastic Syndromes
1
2007
147
0.220
 Why?
Oxygen Consumption
8
2000
724
0.220
 Why?
Quinolines
1
2026
193
0.220
 Why?
Apolipoprotein A-I
2
2018
39
0.220
 Why?
Disease Models, Animal
8
2013
4557
0.220
 Why?
Cardiotonic Agents
3
2005
95
0.220
 Why?
Blood Glucose
6
2024
2327
0.210
 Why?
Natriuretic Peptide, Brain
3
2024
111
0.210
 Why?
Prediabetic State
2
2020
245
0.210
 Why?
Predictive Value of Tests
6
2025
2115
0.210
 Why?
Lanthanum
1
2024
13
0.210
 Why?
Morbidity
5
2017
323
0.210
 Why?
Hyperemia
3
1991
49
0.210
 Why?
Syndrome
6
2007
380
0.200
 Why?
Cause of Death
5
2017
471
0.200
 Why?
Injections, Subcutaneous
2
2024
164
0.200
 Why?
Thiazoles
2
2003
135
0.200
 Why?
Phosphorylation
3
2013
1732
0.200
 Why?
Isoproterenol
3
1998
97
0.190
 Why?
Serine Endopeptidases
2
2014
128
0.190
 Why?
Peroxisome Proliferator-Activated Receptors
4
2017
17
0.190
 Why?
Blood Vessels
1
2024
171
0.190
 Why?
Clinical Trials, Phase II as Topic
2
2019
77
0.190
 Why?
Genes, Bacterial
1
2023
166
0.190
 Why?
Residence Characteristics
3
2016
377
0.180
 Why?
Carcinoma, Hepatocellular
1
2026
370
0.180
 Why?
Calcitriol
2
2003
58
0.180
 Why?
Lipids
3
2024
710
0.180
 Why?
Multicenter Studies as Topic
3
2019
405
0.180
 Why?
Prostatic Neoplasms
5
2003
974
0.180
 Why?
Calcifediol
2
2000
31
0.180
 Why?
Livestock
2
2023
11
0.180
 Why?
Insulin Receptor Substrate Proteins
2
2013
55
0.170
 Why?
Receptors, Cytoplasmic and Nuclear
1
2003
209
0.170
 Why?
Diacetyl
1
2001
7
0.170
 Why?
PPAR alpha
4
2022
54
0.170
 Why?
Indoles
3
2019
501
0.170
 Why?
Artificial Intelligence
1
2026
365
0.170
 Why?
Propensity Score
2
2021
367
0.170
 Why?
Muscles
1
2022
333
0.170
 Why?
Cost-Benefit Analysis
2
2020
634
0.170
 Why?
Mental Status and Dementia Tests
1
2021
26
0.170
 Why?
Oxidative Stress
2
2025
1339
0.160
 Why?
Pancreatic Neoplasms
2
2000
919
0.160
 Why?
Cytokines
2
2005
2061
0.160
 Why?
Myocardial Reperfusion
1
2000
59
0.160
 Why?
Cataract
1
2023
238
0.160
 Why?
Glucagon-Like Peptide-1 Receptor
1
2020
88
0.160
 Why?
Calpain
2
2012
61
0.160
 Why?
Lipoproteins, LDL
2
2014
119
0.150
 Why?
Coronary Artery Bypass
2
2019
268
0.150
 Why?
Matrix Metalloproteinases
1
2000
98
0.150
 Why?
Cadmium
1
2000
69
0.150
 Why?
Liver Neoplasms
1
2026
780
0.150
 Why?
Non-alcoholic Fatty Liver Disease
1
2022
266
0.150
 Why?
Oncogenes
1
2000
119
0.150
 Why?
Perioperative Care
2
2017
231
0.150
 Why?
Renin-Angiotensin System
1
2019
78
0.150
 Why?
Proto-Oncogene Proteins c-akt
2
2013
436
0.140
 Why?
Aged, 80 and over
9
2026
8265
0.140
 Why?
Alkaline Phosphatase
1
2019
145
0.140
 Why?
Adrenergic beta-Agonists
1
1998
92
0.140
 Why?
Adenylyl Cyclases
2
2016
60
0.140
 Why?
Early Termination of Clinical Trials
2
2015
18
0.140
 Why?
Immunoturbidimetry
1
2018
1
0.140
 Why?
United States
7
2023
15966
0.140
 Why?
Carotid Artery Diseases
1
2018
69
0.140
 Why?
Multifactorial Inheritance
1
2019
202
0.140
 Why?
Risk Reduction Behavior
1
2020
226
0.140
 Why?
Collagen
1
2000
456
0.130
 Why?
American Heart Association
1
2019
350
0.130
 Why?
Environment
2
2016
305
0.130
 Why?
Citrate (si)-Synthase
1
2017
57
0.130
 Why?
Pharmacogenetics
2
2016
172
0.130
 Why?
Prostate
1
1998
158
0.130
 Why?
Microalgae
1
2016
10
0.130
 Why?
Ponds
1
2016
17
0.130
 Why?
Transcription Factors
2
2016
1741
0.130
 Why?
Hypertension, Pulmonary
3
2012
1980
0.120
 Why?
Australia
4
2019
286
0.120
 Why?
Administration, Intravenous
1
2017
170
0.120
 Why?
Waste Disposal, Fluid
1
2016
53
0.120
 Why?
HIV Long Terminal Repeat
1
2016
11
0.120
 Why?
Percutaneous Coronary Intervention
2
2019
543
0.120
 Why?
Global Health
2
2017
401
0.120
 Why?
Drug Design
1
2017
173
0.120
 Why?
tat Gene Products, Human Immunodeficiency Virus
1
2016
25
0.120
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2026
1953
0.120
 Why?
Inflammation Mediators
2
2013
509
0.120
 Why?
Simvastatin
2
2015
60
0.120
 Why?
HIV Envelope Protein gp120
1
2016
55
0.120
 Why?
Adult
15
2026
40449
0.120
 Why?
Lipoproteins
2
2014
169
0.120
 Why?
Inflammation
6
2016
2878
0.120
 Why?
Signal Transduction
1
2009
5226
0.120
 Why?
Epigenesis, Genetic
1
2021
684
0.120
 Why?
AMP-Activated Protein Kinases
1
2017
190
0.120
 Why?
Clinical Trials as Topic
2
2018
1053
0.120
 Why?
Postoperative Complications
2
2019
2919
0.110
 Why?
Heart Ventricles
6
2012
760
0.110
 Why?
Glomerular Filtration Rate
3
2026
760
0.110
 Why?
Anti-Arrhythmia Agents
2
2012
142
0.110
 Why?
ATP Binding Cassette Transporter 1
1
2015
13
0.110
 Why?
Platelet Aggregation Inhibitors
1
2019
497
0.110
 Why?
Recombinant Proteins
1
2018
1370
0.110
 Why?
Vasodilation
2
2013
523
0.110
 Why?
Chromosomes, Human, Pair 16
1
2015
35
0.110
 Why?
Smoking
2
2000
1472
0.110
 Why?
Hospital Mortality
1
2019
1030
0.110
 Why?
Wireless Technology
1
2014
18
0.110
 Why?
Bacteria
2
2023
889
0.110
 Why?
Linkage Disequilibrium
1
2015
246
0.100
 Why?
Homeostasis
1
2018
640
0.100
 Why?
Serum Amyloid A Protein
3
2013
32
0.100
 Why?
Transistors, Electronic
1
2014
9
0.100
 Why?
Stents
1
2018
556
0.100
 Why?
Seawater
1
2014
31
0.100
 Why?
Ions
1
2014
71
0.100
 Why?
Heart Rate
5
2001
855
0.100
 Why?
Disease Progression
4
2018
2847
0.100
 Why?
Fresh Water
1
2014
56
0.100
 Why?
Phospholipases A
1
2014
98
0.100
 Why?
Metals, Heavy
1
2014
31
0.100
 Why?
Fasting
1
2015
277
0.100
 Why?
Mendelian Randomization Analysis
1
2013
55
0.100
 Why?
Endovascular Procedures
1
2018
384
0.100
 Why?
Commerce
1
2014
79
0.100
 Why?
Acyl Coenzyme A
1
2013
31
0.100
 Why?
Heart Function Tests
1
2013
59
0.090
 Why?
Ultraviolet Rays
2
1992
388
0.090
 Why?
Hydroxy Acids
1
2012
4
0.090
 Why?
Ventricular Function, Right
1
1995
297
0.090
 Why?
Monitoring, Physiologic
1
2014
289
0.090
 Why?
Ischemic Preconditioning, Myocardial
1
2012
35
0.090
 Why?
Talin
1
2012
10
0.090
 Why?
Decanoic Acids
1
2012
14
0.090
 Why?
Cardiolipins
1
2013
82
0.090
 Why?
Glyburide
1
2012
31
0.090
 Why?
Nitric Oxide Synthase Type III
1
2013
204
0.090
 Why?
Potassium Channel Blockers
1
2012
47
0.090
 Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
1
2012
24
0.090
 Why?
Polymorphism, Genetic
1
2015
612
0.090
 Why?
North America
3
2019
310
0.090
 Why?
Biosensing Techniques
1
2014
139
0.090
 Why?
Case-Control Studies
1
2019
3604
0.090
 Why?
Europe
3
2019
412
0.090
 Why?
Retrospective Studies
6
2018
17066
0.090
 Why?
Keto Acids
3
2019
13
0.090
 Why?
Practice Guidelines as Topic
1
2019
1560
0.090
 Why?
Oxidation-Reduction
4
2025
1087
0.090
 Why?
Hypertension
1
2000
1263
0.080
 Why?
DNA
2
2013
1463
0.080
 Why?
Arteries
1
2013
259
0.080
 Why?
Prospective Studies
2
2021
7990
0.080
 Why?
Tissue Plasminogen Activator
2
2013
244
0.080
 Why?
Genetic Variation
1
2016
983
0.080
 Why?
MAP Kinase Signaling System
1
2013
310
0.080
 Why?
Fractures, Bone
1
2016
414
0.080
 Why?
Manure
2
2023
10
0.080
 Why?
Prejudice
1
2011
60
0.080
 Why?
Myocardial Revascularization
3
2017
85
0.080
 Why?
Death, Sudden, Cardiac
1
2012
230
0.080
 Why?
Electrocardiography
3
2011
662
0.080
 Why?
Phosphorus
5
1995
99
0.080
 Why?
Down-Regulation
2
2024
627
0.080
 Why?
HIV-1
1
2016
896
0.080
 Why?
Gene Expression Regulation
2
2013
2608
0.080
 Why?
United States Department of Veterans Affairs
3
2016
768
0.080
 Why?
Polymers
1
2014
499
0.080
 Why?
RNA, Messenger
3
2015
2832
0.070
 Why?
Age Factors
3
2011
3333
0.070
 Why?
Vitamin D Deficiency
1
1990
186
0.070
 Why?
Critical Care
1
2014
695
0.070
 Why?
Macrophages
1
2016
1511
0.070
 Why?
MicroRNAs
1
2015
701
0.070
 Why?
Vascular Diseases
2
2022
251
0.070
 Why?
Feeding Behavior
1
2014
684
0.070
 Why?
Ventricular Pressure
1
2007
52
0.070
 Why?
Neoplasms
1
2023
2875
0.070
 Why?
Equipment Design
3
2014
530
0.070
 Why?
Diabetes Mellitus
1
2016
1098
0.070
 Why?
Phosphatidylinositol 3-Kinases
1
2009
380
0.070
 Why?
Vitamin D
3
2000
400
0.060
 Why?
Models, Biological
1
2014
1821
0.060
 Why?
Angiomatosis
1
2006
5
0.060
 Why?
Ultrasonography, Interventional
2
2018
160
0.060
 Why?
Hemangioma, Capillary
1
2006
14
0.060
 Why?
Kaplan-Meier Estimate
2
2020
965
0.060
 Why?
Reactive Oxygen Species
1
2009
621
0.060
 Why?
Survival Rate
1
2011
2089
0.060
 Why?
Lactic Acid
2
1998
302
0.060
 Why?
Anti-Inflammatory Agents
1
2009
474
0.060
 Why?
Angina Pectoris
2
2004
75
0.060
 Why?
Ultrasonography
1
2009
770
0.060
 Why?
Cerebrovascular Disorders
2
2017
103
0.060
 Why?
Apolipoproteins E
1
2025
94
0.060
 Why?
Liver
2
2024
1887
0.050
 Why?
Chronic Disease
1
2011
1813
0.050
 Why?
alpha-Tocopherol
1
2004
32
0.050
 Why?
Sus scrofa
1
2004
64
0.050
 Why?
Pulse Wave Analysis
1
2025
266
0.050
 Why?
Linear Models
2
2013
854
0.050
 Why?
Heterozygote
1
2025
315
0.050
 Why?
Arterial Occlusive Diseases
2
1982
90
0.050
 Why?
Vegetables
1
2025
170
0.050
 Why?
Antigen-Antibody Complex
1
2004
72
0.050
 Why?
CD40 Ligand
1
2004
40
0.050
 Why?
Least-Squares Analysis
1
2004
76
0.050
 Why?
Administration, Oral
1
2007
847
0.050
 Why?
Economics, Pharmaceutical
1
2003
10
0.050
 Why?
Muscular Diseases
1
2004
108
0.050
 Why?
Ergocalciferols
1
2003
14
0.050
 Why?
Tumor Cells, Cultured
3
2003
919
0.050
 Why?
Radiation-Sensitizing Agents
1
2003
43
0.050
 Why?
Regional Blood Flow
3
1996
514
0.050
 Why?
Comorbidity
2
2019
1658
0.050
 Why?
Guidelines as Topic
1
2005
267
0.050
 Why?
Lactates
2
1994
83
0.050
 Why?
beta-Lactams
1
2023
32
0.050
 Why?
Death
2
2019
130
0.050
 Why?
Angiotensin Receptor Antagonists
1
2023
114
0.050
 Why?
Creatine Kinase
1
2022
72
0.050
 Why?
Pharmacogenomic Testing
1
2022
62
0.040
 Why?
Multivariate Analysis
2
2017
1539
0.040
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2023
221
0.040
 Why?
Drug Resistance, Bacterial
1
2023
196
0.040
 Why?
Verapamil
1
2001
37
0.040
 Why?
Precision Medicine
1
2025
457
0.040
 Why?
Organ Preservation Solutions
1
2001
47
0.040
 Why?
Receptors, Immunologic
1
2022
206
0.040
 Why?
Antioxidants
1
2004
549
0.040
 Why?
Controlled Clinical Trials as Topic
1
2000
27
0.040
 Why?
Goals
1
2022
183
0.040
 Why?
Ventricular Dysfunction
1
2000
16
0.040
 Why?
Myocardial Stunning
1
2000
4
0.040
 Why?
Tissue Inhibitor of Metalloproteinases
1
2000
19
0.040
 Why?
Collagenases
1
2000
22
0.040
 Why?
Hexamethonium
1
2000
5
0.040
 Why?
Vascular Stiffness
1
2025
486
0.040
 Why?
Liver Cirrhosis
1
2022
288
0.040
 Why?
Atropine
1
2000
37
0.040
 Why?
Soil Microbiology
1
2023
218
0.040
 Why?
Dilatation, Pathologic
1
2000
62
0.040
 Why?
Arrhythmias, Cardiac
1
2003
361
0.040
 Why?
Louisiana
1
2000
28
0.040
 Why?
Interleukin-6
3
2013
780
0.040
 Why?
Dipeptides
2
2012
57
0.040
 Why?
Health Care Costs
1
2003
427
0.040
 Why?
Occupations
1
2000
51
0.040
 Why?
Cell Line
2
2016
2882
0.040
 Why?
Placebo Effect
1
2019
25
0.040
 Why?
Matrix Metalloproteinase 9
1
2000
132
0.040
 Why?
Pericardium
1
2000
62
0.040
 Why?
Ventricular Dysfunction, Left
1
2003
392
0.040
 Why?
Pilot Projects
1
2025
1886
0.040
 Why?
Blood Chemical Analysis
1
2020
109
0.040
 Why?
Phospholipase A2 Inhibitors
1
2019
3
0.040
 Why?
New Zealand
1
2019
54
0.040
 Why?
Insulin Antagonists
1
1998
6
0.040
 Why?
Ventricular Function
1
1999
57
0.040
 Why?
Logistic Models
1
2004
2117
0.040
 Why?
Antigens, CD
1
2022
555
0.040
 Why?
Hormone Antagonists
1
1998
34
0.040
 Why?
Hungary
1
2018
5
0.040
 Why?
Somatostatin
1
1998
51
0.040
 Why?
Placebos
1
2019
192
0.040
 Why?
Israel
1
2018
46
0.040
 Why?
Infusion Pumps
1
2018
32
0.040
 Why?
Pulmonary Artery
2
2006
1134
0.040
 Why?
Netherlands
1
2018
82
0.040
 Why?
Microscopy, Electron
1
1999
415
0.040
 Why?
India
1
2019
218
0.040
 Why?
Drug Combinations
1
2000
390
0.040
 Why?
Elasticity
1
1999
184
0.040
 Why?
Sex Characteristics
1
2024
790
0.030
 Why?
Florida
1
1998
117
0.030
 Why?
Protective Factors
1
2018
99
0.030
 Why?
Drug Interactions
1
2019
398
0.030
 Why?
Algorithms
1
2026
1837
0.030
 Why?
Sex Factors
1
2024
2112
0.030
 Why?
Blood Flow Velocity
1
1999
413
0.030
 Why?
Drug Industry
1
2017
49
0.030
 Why?
Selection Bias
1
2017
38
0.030
 Why?
Catheterization
1
1997
183
0.030
 Why?
Poverty Areas
1
2016
42
0.030
 Why?
Drug Evaluation, Preclinical
1
2017
194
0.030
 Why?
Echocardiography, Transesophageal
1
1997
133
0.030
 Why?
Chi-Square Distribution
1
2017
529
0.030
 Why?
Urban Health
1
2016
96
0.030
 Why?
Erythrocytes
1
2022
757
0.030
 Why?
Pharmacogenomic Variants
1
2016
33
0.030
 Why?
Rural Health
1
2016
87
0.030
 Why?
Cardiac Catheterization
1
2000
560
0.030
 Why?
Drug Discovery
1
2017
155
0.030
 Why?
Viral Tropism
1
2016
36
0.030
 Why?
Internationality
1
2017
156
0.030
 Why?
Receptors, CCR5
1
2016
60
0.030
 Why?
Albuminuria
1
2017
190
0.030
 Why?
Receptors, CXCR4
1
2016
91
0.030
 Why?
Troponin
2
2007
49
0.030
 Why?
CD4 Antigens
1
2016
139
0.030
 Why?
Immunoglobulin M
2
2009
284
0.030
 Why?
Attitude of Health Personnel
1
2004
1185
0.030
 Why?
Membrane Proteins
1
2022
1166
0.030
 Why?
Fatty Acids
1
1998
450
0.030
 Why?
Body Mass Index
1
2024
2438
0.030
 Why?
Myalgia
1
2015
13
0.030
 Why?
Angioplasty, Balloon, Coronary
1
1996
157
0.030
 Why?
Genome-Wide Association Study
1
2022
1406
0.030
 Why?
Physicians
1
2004
939
0.030
 Why?
Creatinine
1
2017
506
0.030
 Why?
Receptors, LDL
1
2015
53
0.030
 Why?
Electromagnetic Radiation
1
2014
3
0.030
 Why?
Cognitive Dysfunction
1
2021
461
0.030
 Why?
Thrombolytic Therapy
1
1996
163
0.030
 Why?
Carotid Intima-Media Thickness
1
2015
75
0.030
 Why?
Social Class
1
2016
268
0.030
 Why?
Myositis
1
2015
57
0.030
 Why?
Chemotherapy, Adjuvant
1
1996
421
0.030
 Why?
Lidocaine
1
1994
54
0.030
 Why?
Quality of Life
1
2007
3185
0.030
 Why?
Fat Emulsions, Intravenous
1
1994
29
0.030
 Why?
Hypertrophy, Left Ventricular
1
1995
124
0.030
 Why?
Calibration
1
2014
151
0.030
 Why?
Adenosine
2
1994
255
0.030
 Why?
Osmolar Concentration
1
1994
167
0.030
 Why?
Analysis of Variance
1
2017
1306
0.030
 Why?
Electric Stimulation
1
1995
276
0.030
 Why?
ATP-Binding Cassette Transporters
1
2015
118
0.030
 Why?
Semiconductors
1
2014
38
0.030
 Why?
Seasons
1
2016
556
0.030
 Why?
Adenosine Diphosphate
1
1994
84
0.030
 Why?
Stroke Volume
1
1997
651
0.030
 Why?
Pressure
1
2014
225
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2000
1455
0.030
 Why?
Mice
3
2016
18339
0.020
 Why?
NAD
1
1994
81
0.020
 Why?
Solutions
1
2014
166
0.020
 Why?
Patient Outcome Assessment
1
2014
134
0.020
 Why?
Mitochondria, Heart
1
1994
102
0.020
 Why?
Glycine
1
1994
187
0.020
 Why?
Hyperglycemia
1
2017
375
0.020
 Why?
Vascular Cell Adhesion Molecule-1
1
2013
40
0.020
 Why?
Perioperative Period
1
2013
71
0.020
 Why?
Materials Testing
1
2014
354
0.020
 Why?
Heparin
1
1994
244
0.020
 Why?
Binding Sites
1
2016
1329
0.020
 Why?
Oxidative Phosphorylation
1
1994
210
0.020
 Why?
Dose-Response Relationship, Radiation
1
1992
140
0.020
 Why?
Immunoglobulin G
2
2009
893
0.020
 Why?
Nutrition Surveys
1
2014
282
0.020
 Why?
Actinin
1
2012
12
0.020
 Why?
Dogs
3
1984
437
0.020
 Why?
Anti-Bacterial Agents
1
2023
1907
0.020
 Why?
Weight Gain
1
2016
556
0.020
 Why?
Socioeconomic Factors
1
2016
1326
0.020
 Why?
Mathematics
1
1992
100
0.020
 Why?
South Africa
1
2013
261
0.020
 Why?
Cardiac Output, Low
1
1992
54
0.020
 Why?
Cardiomyopathy, Dilated
2
1992
359
0.020
 Why?
Patient Selection
1
1996
719
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2012
331
0.020
 Why?
Vascular Resistance
2
1984
367
0.020
 Why?
Biopsy
1
1995
1075
0.020
 Why?
Reperfusion
1
1991
54
0.020
 Why?
Perfusion
1
1992
250
0.020
 Why?
Disease-Free Survival
1
2013
769
0.020
 Why?
Poisson Distribution
1
2011
78
0.020
 Why?
Georgia
1
2011
83
0.020
 Why?
Constriction
1
1990
47
0.020
 Why?
Vitamin D-Binding Protein
1
1990
15
0.020
 Why?
Cross-Sectional Studies
2
2014
5868
0.020
 Why?
Anticoagulants
1
1996
722
0.020
 Why?
Cells, Cultured
1
1998
4154
0.020
 Why?
Patient Discharge
1
2017
983
0.020
 Why?
Alleles
1
2013
879
0.020
 Why?
Regression Analysis
1
1992
1003
0.020
 Why?
Cell Division
2
2003
766
0.020
 Why?
Cognition Disorders
1
2014
538
0.020
 Why?
Hypoglycemia
1
2015
477
0.020
 Why?
Autoantibodies
2
2009
1501
0.020
 Why?
Polymorphism, Single Nucleotide
1
2016
2145
0.020
 Why?
Fibrin Fibrinogen Degradation Products
1
2009
93
0.020
 Why?
Educational Status
1
2011
467
0.020
 Why?
Young Adult
2
2016
14105
0.020
 Why?
Thromboembolism
1
2009
125
0.020
 Why?
Environmental Exposure
1
1992
588
0.020
 Why?
Spectrin
1
2007
14
0.020
 Why?
Desmin
1
2007
24
0.020
 Why?
Densitometry
1
2007
37
0.020
 Why?
Sarcoplasmic Reticulum Calcium-Transporting ATPases
1
2007
33
0.020
 Why?
Databases, Factual
1
2013
1486
0.020
 Why?
Poverty
1
2011
529
0.020
 Why?
Heart Diseases
1
1990
349
0.020
 Why?
Calcium-Binding Proteins
1
2007
219
0.020
 Why?
Kidney
1
2014
1495
0.010
 Why?
ROC Curve
1
2007
614
0.010
 Why?
Fatal Outcome
1
2006
307
0.010
 Why?
Protein Processing, Post-Translational
1
2007
477
0.010
 Why?
Aminophylline
1
1984
12
0.010
 Why?
Vasomotor System
1
1984
46
0.010
 Why?
Solubility
1
2004
242
0.010
 Why?
Mice, Inbred C57BL
1
2014
5992
0.010
 Why?
Radiation, Ionizing
1
2003
87
0.010
 Why?
DNA, Neoplasm
1
2003
163
0.010
 Why?
Health Care Surveys
1
2004
539
0.010
 Why?
Immunohistochemistry
1
2006
1716
0.010
 Why?
Odds Ratio
1
2004
1075
0.010
 Why?
Electrophysiology
1
1982
218
0.010
 Why?
Echocardiography
2
1997
652
0.010
 Why?
Blotting, Western
1
2003
1187
0.010
 Why?
Vascular Surgical Procedures
1
2004
339
0.010
 Why?
Mixed Function Oxygenases
1
2000
49
0.010
 Why?
Chemoprevention
1
2000
90
0.010
 Why?
Hydrogen-Ion Concentration
2
1991
561
0.010
 Why?
Adolescent
2
2016
22428
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2000
983
0.010
 Why?
Thorax
1
1997
50
0.010
 Why?
Phosphorus Isotopes
1
1995
8
0.010
 Why?
Infusions, Parenteral
1
1994
41
0.010
 Why?
Apoptosis
1
2003
2430
0.010
 Why?
Cardiac Pacing, Artificial
1
1995
84
0.010
 Why?
Basal Metabolism
1
1994
62
0.010
 Why?
Substrate Specificity
1
1995
388
0.010
 Why?
T-Lymphocytes
1
2002
1982
0.010
 Why?
Glycolysis
1
1995
339
0.010
 Why?
Lung
1
2006
4109
0.010
 Why?
Stimulation, Chemical
1
1992
53
0.010
 Why?
Rats, Sprague-Dawley
1
1997
2527
0.010
 Why?
Diphosphoglyceric Acids
1
1991
3
0.010
 Why?
2,3-Diphosphoglycerate
1
1991
32
0.010
 Why?
Radio Waves
1
1991
28
0.010
 Why?
Cardiomegaly
1
1990
174
0.000
 Why?
Rats
1
1997
5597
0.000
 Why?
Theophylline
1
1984
41
0.000
 Why?
Heart Block
1
1984
40
0.000
 Why?
Oxygen
1
1984
995
0.000
 Why?
Magnetic Resonance Imaging
1
1990
3863
0.000
 Why?
Schwartz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (589) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)